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A B S T R A C T
Vitamin A plays a vital role during embryo development as most precursor of embryonic retinoic acid, a key
morphogen during embryogenesis. Carotenoids, including β-carotene, are important vegetal source of Vitamin A
and in contrast to teratogenic potential of animal-derived retinoids, β‐carotene is usually considered freed from
embryotoxic effects and supplements in pregnancy with β-carotene are suggested. The aim of the present work is
to evaluate the effect of bulk and nano-encapsulated β-carotene on embryo development, by using the animal
model Frog Embryo Teratogenesis Assay: Xenopus- FETAX. Xenopus laevis embryos were exposed from late
gastrula till pharyngula (the phylotypic stage for vertebrates) to the concentrations of BULK β-carotene 150-
3000 ng/mL and NANO β-carotene 0.75-30 ng/mL. At pharyngula stage, some embryos were processed for
whole mount neural crest cell immunostaining, while others embryos were allowed to develop till tadpole for
morphological and histological evaluation of neural crest cells-derived structures. In this model, the nano-en-
capsulated β-carotene induced specific malformations at craniofacial and eye level, while the bulk formulation
only induced developmental delays. Finally, the applied alternative animal model resulted a rapid and sensitive
screening method able to re-evaluate the teratogenic profile of nano-encapsulated micronutrients.
1. Introduction
Vitamin A plays a key role during embryo development because it’s
the main precursor of embryonic retinoic acid (RA), a crucial mor-
phogen during embryogenesis [1]. In mammalian species, RA is es-
sential during the developmental and reproductive phases for directing
the growth and differentiation of cells, tissues and organs [2,3]. In
vertebrates, RA is also considered the main molecule involved in cra-
niofacial morphogenesis in vertebrates, and in activating the expression
of a cascade of growth factors and genes controlling craniofacial de-
velopment [4].
The deficiency, as well as the excess of embryonic RA, is associated
with malformations in many districts, including cranio-facial defects in
humans and animals [1,3,5–9]. Therefore, the regulation of RA amount
that is available to the embryo at specific times and to a given site is of
critical importance.
In rats, congenital malformations caused by the administration of
vitamin A excess during pregnancy were first described by Cohaln
(1954) [10], and later confirmed with overlapping defects patterns in
different animal species [11].
The similarities of the teratological effects of vitamin A deficiency
and excess indicates common targets and an important role for vitamin
A in the embryo development [12].
These teratogenic effects, produced by vitamin A over-intake or the
clinical use of synthetic retinoids, are classified as FRS (Fetal Retinoid
Syndrome). Among characteristics of FRS, cranio-facial defects and
encephalic, cardio-vascular and thymic abnormalities are reported
[13]. Vitamin A or retinoids supplementation should be, by con-
sequence, contraindicated during pregnancy.
Carotenoids, including β-carotene, are an important vegetal source
of vitamin A; in mammals they are obtained from the mother, and in
egg-laying species they are stored in the eggs as provitamin A. Thanks
to their molecular structure, carotenoids show anti-inflammatory and
antioxidant activities such as binding and eliminating several free ra-
dicals, ROS included and quenching singlet oxygen, thus suppressing
lipid peroxidation and preventing oxidative damage [14]. For this
reason, a diet rich in fresh vegetables with a high vitamins content
(especially vitamins C and E) and other substances such as carotenoids
has long been suggested, in mammals, including humans, as a protec-
tion against cardiovascular diseases, tumors and inflammatory states
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[14].
In human nutrition β-carotene contributes more than 30 % to vi-
tamin A intake in Western countries, and in many populations it is the
exclusive source of vitamin A [15]. It has been established that the
recommended daily dose of vitamin A (retinol) is 600 μg/day in adult
women, 700 μg/day in pregnant women and 1000 μg/day during lac-
tation, which corresponds to approximately 3.6, 4.2 and 6mg/day of β-
carotene, respectively [16]. The maximum tolerable dose of vitamin A
is 3000 μg/day, corresponding to 18mg/day of β carotene [16].
In contrast to teratogenic potential of animal-derived retinoids,
β‐carotene is usually considered free of embryotoxic effects [17,18] and
supplements before, during and after pregnancy with β-carotene have
been suggested. In fact, it has been proved that β-carotene could be
useful to achieve the necessary quantity of vitamin A for the correct
embryonic development, improving fetal development and growth, and
reducing the incidence of preterm births, birth defects, risk of infections
and postpartum mortality [15].
β-carotene is photosensitive and because of its strong antioxidant
action it can oxidize very quickly causing alterations of the product to
which it is supplemented [19]. In order to improve the stability and the
bioavailability of this compounds, β-carotene is also used for supple-
mentation in nano-encapsulated form, despite the toxico-kinetic and
toxico-dynamic profile obtained for the bulk form is probably different
after nano-encapsulation [20].
In recent years, nano-encapsulation technology greatly increased in
food industry thanks to its advantages. Nano-encapsulation is generally
used to deliver different nutraceutical products and bioactive molecules
like vitamins and antioxidants, allowing production of functional foods
with enhanced functionality and stability by protecting the en-
capsulated materials from environmental, enzymatic and chemical
changes, and by ameliorating their organoleptic properties [21]. Lipid-
based nano-encapsulation systems enhance, for example, the perfor-
mance of lipophilic molecules by improving their solubility. In these
systems, the lipophilic substance (core) is surrounded by an amphi-
philic coat (shell) made of surface-active material that enhances solu-
bility in aqueous media [22]. Nano-encapsulation provides significant
savings to formulators, because it reduces the amount of active in-
gredients, increasing their bioavailability and shelf-life [23]. Never-
theless, nano-encapsulation raised some questions about the potential
toxic effects of nano-encapsulated nutrients in food and beverages on
human health and environment. This technology can, infact, modify
absorption, distribution, metabolism, and excretion processes [24,25].
For these reasons, the European Food Safety Agency (EFSA) and the
Food and Drug Administration (FDA) promoted the search for valid
alternative methods able to identify and evaluate the risks deriving
from nanotechnologies [26].
Simple culture systems, like rat and Xenopus laevis embryos in vitro
development, have already been proposed as animal models to assess
the developmental toxicity of nano-encapsulated molecules and the
effects of nutrient excess or deficiency on embryos [27–33] thanks to
the interclass's similarities at both morphological and molecular level at
the phylotypic stages (pharyngula, as named by Ballard [34], corre-
sponding in vertebrates to the neurulation and branchial arch organi-
zation stages). However, because of physiological differences in provi-
tamin A carotenoid absorption between rodents and humans, rodents
are not suitable animal models for studying human carotenoid ab-
sorption [35,16].
Among the non-mammalian models, the standardized Frog Embryo
Teratogenesis Assay: Xenopus (FETAX) test represents a high sensitive
tool to evaluate potential embryotoxicity effects [36–39]. Based on the
amphibian Xenopus laevis, FETAX protocol is a well known and pow-
erful bioassay used not only to screen the teratogenic potential of single
compounds (developmental toxicants, such as pesticides or some metal
oxide nanoparticle), but also to evaluate their possible joint action
[31,40–45]. Due to its rapid aquatic development, numerous and large
size eggs and easily manipulating embryos, X. laevis is one of the most
used model system for vertebrate experimental embryology [36]. These
characteristics led to the development of assay conditions to system-
atically test the teratogenicity of any chemical compound of interest
and to determine and categorize the induced developmental mal-
formations [37]. In recent years, thanks to its ability to predict human
teratogens with a 75 % accuracy [30], the use of FETAX has been ex-
tended to the establishment of models for human diseases in addition to
its classical use as ecotoxicological test [45,46]. Last but not least,
FETAX is considered an alternative animal-free model, and as such is
not subject to mandatory regulative rules [32].
Moreover, it must be considered that nano-encapsulation of Vitamin
A was demonstrated to be able to enhance embryotoxicity in different
developmental models, X. laevis included [47].
The aim of the work is to evaluate and compare the effect of bulk
and nano-encapsulated β-carotene on X. laevis embryo development by
using a modified version [47] of the alternative animal-free model
FETAX, with the final goal to eventually reconsider vitamin nano-en-
capsulation toxicological evaluation.
2. Material and method
2.1. Chemicals
All analytical grade reagents, β-carotene (BULK β-carotene), 3-
amino-benzoic acid ethylester (MS222) and salts for FETAX solution
were purchased from Sigma-Aldrich S.r.l., Italy. The traded nano-for-
mulations with (NANO β-carotene) or without (SHELL) encapsulated β-
carotene were kindly provided by Aquanova® (Novasol® GmbH,
Germany). All suspensions and solutions were prepared in FETAX
whose composition in mg/L was: 625 NaCl, 96 NaHCO3, 30 KCl, 15
CaCl2, 60 CaSO4 %2H2 O, and 70 MgSO4). For every experiment, solu-
tions were freshly prepared and maintained in the dark. Nano micelles
(with or without β-carotene) have been supplied as a 1% emulsion in
vegetable oil of nanoliposomes, formed by a shell of lipids from soya
lecithin and a core of β-carotene (NANO β-carotene) or lecithin itself
(SHELL). The product micelle is stable with respect to pH and tem-
perature and has a diameter of approximately 30 nm.
2.2. Experimental design
2.2.1. FETAX methodology
Each assay was performed in triplicate. Adults of X. laevis (Harlan
Italia, Bresso, Italy) were maintained in controlled conditions
(T=20+2 °C; pH=7.5+0.5; Conductivity= 1000 ± 100 μS; 12 h
light/dark cycle) in an automatic breeding system (TecnoPlus,
Techniplast, Italia) and fed a semisynthetic diet two times per week
(XE40 by Mucedola; Settimo Milanese, Italy). Embryos were obtained
from natural mating of couples. After mating, embryos transferred in
Petri dishes and processed according to Battistoni et al. [47].
Embryos were exposed from NF stage 13 (early neurula stage) to NF
stage 26 (phylotypic stage) [36] to BULK β-carotene (150–300 –
750–1500 ng/mL dissolved in DMSO) or NANO β-carotene (0.75–1.5 –
3–7.5 – 15–30 ng/mL dissolved in FETAX). BULK and NANO β-carotene
concentrations were selected on the basis of preliminary range finding
tests, considering the maternal plasma concentrations reported in
Goldberg as reference to set concentrations for the bulk form [48]. A
control group exposed to the shell alone (SHELL) and a control group
containing the solvent used for the bulk form (1 μL DMSO /mL FETAX,
CON+DMSO) were also prepared. At NF stage 26, 5 embryos/group/
replicate were processed for immunostaining, while the remaining were
removed from treatment solution, rinsed and incubated in FETAX so-
lution. Morphology was evaluated when NF 37 and 46 were reached in
controls. At NF stage 37 and 46, 5 embryos/group/replicate were also
processed for histological evaluation.
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2.2.2. Immunostaining for CRABPI
Immunostaining of CRABPI was used to visualize the migrating
neural crest cells [49]. The whole mount immunostaining procedures
on X. laevis embryos have been previously described respectively in
Menegola et al. [50] and Di Renzo et al. [41]. The monoclonal antibody
was the anti-CRABPI (cellular retinoic acid binding protein), ABR, Italy,
dilution 1:500. The anti-mouse-Ig-peroxidase (Fab fragment Boeh-
ringer, Italy) was diluted 1:40. Immunoreactivity was visualized with
the substrate 4-Cl-1-naphtol (Sigma, Italy) and 0.006 % H2O2. Stained
cells appeared dark brown at light microscope. Negative control was
performed without primary antibody incubation.
2.2.3. Histological analysis
For the histological analysis, control and exposed larvae at NF stage
37 and 46 were overdosed with anesthetic MS-222 and fixed overnight
in Bouin’s fluid. After fixation, larvae were rinsed in tap and distilled
water, dehydrated in an ascending ethanol series and embedded in Bio-
plast tissue embedding medium (Bio-optica, Italy). Seven micrometers
frontal serial sections of the entire larvae were obtained by a Reichert
rotative microtome and stained with Hematoxylin-Eosin. All larvae
organs and tissues were considered.
2.2.4. Acridine orange
In order to obtain a detailed and three-dimensional view of the
morphological structures, control and exposed larvae at NF stages 37
and 46 were overdosed with anesthetic MS-222, fixed in 10 % buffered
formalin overnight at 4 °C, rinsed and stained with acridine orange
(Sigma, Italy; 5 mg/mL PBS), according to the method described by
Zucker et al. [51] and, after washing in PBS, viewed under a fluores-
cence microscope.
2.3. Statistical analysis
Data on abnormalities, expressed in percentage of malformed sam-
ples, were analyzed by Chi-square test. The level of significance was set
at p < 0.05.
2.4. Benchmark-dose analysis
Benchmark-dose (BMD) method was applied on abnormalities. Data
were modeled by using PROAST 67 software in order to characterize
the single dose response curves on total abnormal larvae and to find the
relative potency factor (RPF) of BULK versus NANO β-carotene.
Additionally, dose-response evaluation of specific effect categories
(classified as malformations, severe malformations and extreme mal-
formations) and their BMDs for Benchmark-response (BMR) at 50 % of
NANO β-carotene was performed.
3. Results
3.1. Stage 46 larvae, morphological evaluation
Controls and X. laevis larvae exposed from NF stage 13 to NF stage
26 to the BULK and NANO β-carotene at the end of the test reached NF
stage 46. The totality of unexposed larvae developed normally, dis-
playing well distinguishable craniofacial portions, well-expanded gill
basket, linear brain parallel to the body axis and normally developed
eye. No malformations were recorded in larvae exposed to BULK β-
carotene at any tested concentration. Anyway, developmental delays
were recorded starting from dose 750 ng/mL with consequent decrease
of larvae displaying normal phenotype with a significant linear trend
(Fig. 1 A-A’; Table 1).
On the contrary, the exposure to NANO β-carotene resulted effective
in inducing developmental delays and abnormal development of the
head in a concentration-dependent manner, with a significant linear
trend (p < 0.01). Malformed larvae were recorded starting from dose
1.5 ng/mL and at dose 7.5 they appeared with different grade of se-
verity (Fig. 1; Table 1). Dose 15 ng/mL resulted 100 % teratogenic and
the 92.6 % of larvae exposed to 30 ng/mL showed the most severe
phenotype (Table 1). The BMDs for BMR at 50 % resulted nearly 4, 7
and 10 nM respectively for malformations, severe malformations and
extreme malformations (Fig. 2).
In detail, sever reduction of the anterior dorsal part of the head
Fig. 1. Morphological appearance of NF stage 46 larvae before (A-B-C-D) and
after fixation and acridine orange staining according to Zucker et al. [51] (A’-B’-
C’-D’). Magnification 20X (A-B-C-D); magnification 32X (A’-B’-C’-D’).
A: lateral view of a control larva with normal phenotype. Note the dorsal neural
tube (NT), the well-expanded gill basket (GB), the normal eye (*), the intestine
(I) and the oral opening (arrow).
A': frontal view of a larva with normal phenotype stained with acridine orange.
The naris (o) are well distinguishable, as well as the well-expanded oral cavity
(‘’).
B: lateral view of a NANO β-carotene 3 ng/mL larva with malformed phenotype
with round-shape head (NT).
B': frontal view of a malformed larva with round-shape head stained with ac-
ridine orange. The nasal pits (o) are well formed but in a different inclination
due to the round-shape head. The oral cavity present marked reduction ac-
companied by oedema (arrow).
C: lateral view of a larva exposed to NANO β-carotene 7,5 ng/mL with severely
malformed phenotype with round-shape and coerced head. Note the extremely
reduced oral cavity (>), the abnormal shape of the eye (< <) and the pre-
sence of oedema in the cardiac region (*).
C': frontal view of a severely malformed larva with round-shape and coerced
head stained with acridine orange. Note the nasal pits barely visible (o), the
abnormal eyes (< <) and the altered oral cavity (arrow).
D: lateral view of a larva exposed to NANO β-carotene 30 ng/mL with ex-
tremely malformed phenotype with funnel shaped oral cavity (>). Note the not
linear and swollen neural tube (NT), the abnormal eye with half-moon shape
(< <) and the oedema in the cardiac region (*).
D': frontal view of an extremely malformed larva with funnel shaped oral cavity
stained with acridine orange. Note the irregular nasal pits (o), the half-moon
shape eye (> >) and the oral cavity, almost a small split (arrow).
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accompanied by edema at the level of oral cavity and of the craniofacial
and cardiac regions, a marked reduction of the oral opening, abnormal
eye and abnormal position of the adhesive organ and of the gills were
recorded. Digestive tract and the tail were normally shaped (Fig. 1 B-C-
D). The acridine orange staining highlighted the abnormalities at the
eyes and at the oral cavity (Fig. 1 B’-C’-D’).
The BMD approach indicated a RPF for the BULK versus NANO β-
carotene equal to 6*10−4 (C.I. (Fig. 3).
3.2. Histological evaluation
At the histological examination, cartilaginous head elements ap-
peared abnormally shaped and fused in abnormal NANO β-carotene
exposed larvae (Fig. 4). The presence of schisis at the anterior portion of
the head was observed, with the impossibility to structure the naris. A
progressive reduction of the cartilaginous elements of the ethmoid and
of the maxillary arch was also associated with the schisis, as well as the
presence of oedema in the mesenchyme of the oral cavity. The eva-
luation of the histological slides also revealed important abnormalities
at the eye level, with progressive folding of the epithelium based on the
Table 1
Abnormalities observed in X. laevis larvae after BULK and NANO β-carotene exposure (%).
CONT+DMSO BULK 300 BULK 750 BULK 1500 BULK 3000
Total examined 37 10 29 29 58
Normal ** 94.59 100.00 68.97 82.76 58.62
Developmental delay ** 5.41 0.00 31.03 17.24 41.38
Abnormal 0.00 0.00 0.00 0.00 0.00
malformed 0.00 0.00 0.00 0.00 0.00
severly malformed 0.00 0.00 0.00 0.00 0.00
extremely malformed 0.00 0.00 0.00 0.00 0.00
SHELL NANO 075 NANO 1,5 NANO 3 NANO 7,5 NANO 15 NANO 30
Total examined 13 24 44 44 44 10 27
Normal ** 100.00 95.83 63.64 31.82 0.00 0.00 0.00
Developmental delay ** 0.00 4.17 29.55 40.91 4.55 0.00 0.00
Abnormal ** 0.00 0.00 6.82 27.27 95.45 100.00 100.00
malformed ** 0.00 0.00 2.27 27.27 31.82 20.00 0.00
severly malformed ** 0.00 0.00 2.27 0.00 29.55 20.00 7.41
extremely malformed ** 0.00 0.00 2.27 0.00 34.09 60.00 92.59
** p < 0.001, Chi-squared test for trend.
Fig. 2. Evaluation of the benchmark doses (BMDs) for Benchmark-response (BMR) at 50 % of the different categories (malformations, severe malformations and
extreme malformations) observed in larvae exposed to NANO β-carotene. Malformations: continuous dose-response curve; Severe malformations: dashed dose-
response curve; Extreme malformations: dotted dose-response curve.
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grade of severity of the malformations registered at the external eva-
luation. Nevertheless, the differentiation of the different eye cell po-
pulations was maintained in all malformed larvae (Fig. 4 B-D’).
3.3. Morphological evaluation of stage 37 embryos
In order to evaluate the morphogenetic events at the base of the
observed malformation, embryos at stage 37 were morphologically
evaluated. Control embryo showed well pigmented eyes and well-
formed adhesive organ. At the histological examination, the eye had
differentiated retina with crystalline of acceptable dimensions and in a
central position with respect to the optical cup. Stomodeal and phar-
yngeal cavity were well introflexed and ready to originate the oral
cavity (Fig. 5).
On the contrary, the morphological evaluation of embryos exposed
to NANO β-carotene showed abnormalities at the eye level with altered
pigment distribution only visible in the upper area of the eye (Fig. 6 A).
The acridine orange staining revealed an alteration in the devel-
opment of crystalline and the absence of the telencephalic vesicles. In
addition, stomodeum appeared reduced (Fig. 6 B–C).
At the histological examination the eye structure appeared ex-
tremely compromised in larvae exposed to NANO β-carotene 15 ng/mL:
the epithelium of the optical cup was folded several times on itself and
the modest-size crystalline was segregated in lateral position (Fig. 6 D-
D'). Finally, in larvae exposed to NANO β-carotene 30 ng/mL the re-
duced funnel-shaped stomodeum did not reached the epithelium of the
anterior intestine (Fig. 6 E-E’).
3.4. Whole mount CRABPI immunostaining stage 26
After CRABPI immunostaining, control X. laevis embryos at stage 26
showed immunostained tissues distributed around the optic and otic
vesicles, at the level of the frontal region and at the level of the bran-
chial arches. The distinct migratory flows of migrating cells were well
distinguishable from the rhomboencephalon to the branchial arches,
where the ectomesenchyme appeared condensed (Fig. 7 A-A’). Embryos
exposed to NANO β-carotene show different degree of disorganization
Fig. 3. Evaluation of the relative potency factor (RPF) of the NANO formulation
(dose-response curve with crosses) in respect to the BULK form (dose-response
curve with triangles) of β-carotene. RPF was calculated at the effective con-
centration at 50 % (EC50). RPF of the nano-encapsulated β-carotene was
6*10−4 (BMD modelling by using PROAST software).
Fig. 4. Frontal histological sections of NF stage 46 control and exposed larvae.
A: Dorsal view of a control larva with normal phenotype. Note the well-ex-
panded ethmoid cartilage (E) in the anterior portion of the head and laterally to
the olfactory mucosa (o). The eyes (*) and the well-developed intestine (I) are
visible. Magnification 25× .
A': Detail of the eye: note the pigmented layer (*) and the photoreceptor, bi-
polar cell and multipolar layers of the retina (>) Magnification 400× .
B: Dorsal view of a larva exposed to NANO β-carotene 3 ng/mL with malformed
phenotype. Note the anterior schisis (black arrow) and the moderate oedema in
the mesenchyme of the oral cavity (*). Magnification 25× .
B': Detail of the eye: note the slight folding at the level of the layers of the retina
(<). Magnification 100× .
C: Dorsal view of a larva exposed to NANO β-carotene 7,5 ng/mL with severely
malformed phenotype. Note the anterior schisis (§) and the opened branchial
basket (*). Magnification 25× .
C': Detail of the eye: note the prominent folding of different layers of the retina
(> >) and the abnormal shape of the crystalline (arrow). Magnification
100× .
D: Dorsal view of a larva exposed to NANO β-carotene 7,5 ng/mL with ex-
tremely malformed phenotype. Note the ethmoid cartilage with elongated and
flattened shape (E) and the oedematous mesenchyme (*). Magnification 25× .
D': Detail of the anterior portion: note the disorganized tissues at the level of the
nasal pits (>) and at the eye level with no centrally positioned crystalline (§)
M. Battistoni, et al. Toxicology Reports 7 (2020) 510–519
514
of CRABPI positive tissues: embryos exposed to dose 3 ng/mL showed
partially altered migration streams with interconnection areas between
frontonasal and branchial portions (data not shown). Embryos exposed
to dose 30 ng/mL showed partially fused migration streams and con-
tinuous immunostained mass into the branchial region (Fig. 7 B-B’).
4. Discussion
β-carotene is a substance of plant-derived origin widely used both in
the food industry and in the chemical-pharmaceutical industry as
source of vitamin A [15]. The absorption of β-carotene appears to be
highly variable in the population (5–65 %), depending on food- and
diet-related factors, genetic characteristics and the health status of the
subject [16].
As form of provitamin A, β-carotene is often recommended as a
dietary supplement (also in nano-encapsulated form) for pregnant
women, in order to prevent the effects of hypovitaminosis A (vitamin A
is essential for embryonic development) [52,53]. In fact, low or ex-
cessive doses of vitamin A have been shown to be teratogenic, while
toxicity studies in animals have shown that β-carotene in his bulk form
is not embryotoxic or teratogenic and does not cause hypervitaminosis
A [54].
Anyway, strong evidence suggests that the fetus has limited capacity
to store β-carotene and convert most of it to RA [48]. By consequence,
an increase in fetal β-carotene exposure could lead to an increase of
fetal RA levels.
Nano-encapsulation raised some questions about the potential toxic
effects of nano-encapsulated nutrients in food and beverages on human
health and environment because it may modify absorption, distribu-
tion, metabolism, and excretion processes [24,25]. Previously pub-
lished data on two different alternative animal models (rat whole em-
bryo culture and FETAX) showed that nano-encapsulation significantly
increases vitamin A embryotoxicity, probably enhancing vitamin A
and very folded retinal layer separated by the pigmented layer (#).
Magnification 100× .
Fig. 5. Morphological appearance of a NF stage 37 control larva before (A) and after fixation and acridine orange staining according to Zucker et al. [51] (B, C), with
the corresponding histological sections (D, D’, E, E’).
A: Lateral view of a control larva with normal phenotype. Note the well-developed eye (*). Magnification 10× .
B: Lateral view of a control larva with normal phenotype stained with acridine orange. Note the eye pigment circularly positioned and the centrally positioned
crystalline (*).Magnification 40× .
C: Frontal view of a control larva with normal phenotype stained with acridine orange. Note the round-opened stomodeum (s) and the forebrain bulges (t).
Magnification 40× .
D: Dorsal section of a control larva. Note the optical nerve (>) and the eye structure with centrally positioned crystalline and retinal layer already differentiated (*).
Magnification 100× .
D': Detail of the eye. Note the crystalline with different layers (*) and the regularly organized retinal layers (>). Magnification 400× .
E: Ventral section of a control larva. Note the well-introflexed stomodeum (> >). Magnification 100× .
E': Detail of E. Note the stomodeal ectoderm (black>) and the pharyngeal endoderm (red>) which are about to merge. Magnification 400× .
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bioavailability [48].
The aim of this work was then to compare the effect of nano-en-
capsulated β-carotene to the bulk form (for which available tox-
icological data allow to classify β-carotene as safe during gestation). We
used the alternative animal-free models Frog Embryo Teratogenesis
Assay: Xenopus- FETAX. The selected concentrations for the bulk form
were in the range of maternal plasma levels [49].
Our results indicated that in X. laevis embryos, during the mor-
phogenetic phylotypic stages, the tested BULK β-carotene concentra-
tions induced only developmental delays, starting from dose 750 ng/
mL. On the contrary, the exposure to NANO β-carotene revealed that all
tested concentrations were effective in inducing specific malformations
at cranio-facial and eye level, although they were one hundred time
lower than the BULK form. Only NANO β-carotene 0.75 ng/mL resulted
ineffective in inducing malformations but was able to induce develop-
mental delays.
The reported malformations, however, were not comparable to the
alterations described for hypervitaminosis A, but seemed to be related
to severe hypovitaminosis A obtained experimentally by inhibiting the
retinoic acid receptors (RAR) or the RALDH2 enzyme as reported in
Kennedy [55]. In their study, they showed that RA is required for the
formation of the upper lip and primary palate in Xenopus laevis and a
Fig. 6. Morphological appearance of NF stage 37 larvae exposed to NANO β-carotene before (A) and after fixation and acridine orange staining according to Zucker
et al. [51] (B, C), with the corresponding histological sections (D, D’, E, E’).
A: Lateral view of a larva exposed to NANO β-carotene 15 ng/mL with alteration at the cephalic portion. Note the half-shape of the eye (>). Magnification 10× .
B: Lateral view of a larva with alteration at the cephalic portion stained with acridine orange. Note the pigmented layers in the upper side of the eye (>). It is not
possible to note the crystalline. Magnification 40× .
C: Frontal view of a larva with alteration at the cephalic portion stained with acridine orange. Note the narrowed stomodeum (<). It is not possible to note the
forebrain bulges. Magnification 40× .
D: Dorsal section of a larva exposed to NANO β-carotene 15 ng/mL. Note the compromised eye structure with reduced crystalline (>) and with over folded retinal
layers (arrow). Magnification 100× .
D': Detail of the eye. Note the reduced crystalline (>) and the disorganized layers of the retina (*). Magnification 400× .
E: Ventral section of a larva exposed to NANO β-carotene 30 ng/mL. Note the reduced stomodeum (> >). Magnification 100× .
E': Detail of the reduced stomodeum (>). Magnification 400× .
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loss of RA signalling, by RALDH2 or RAR inhibition, resulted in a
median facial cleft. Median facial hypoplasia, or median cleft lip and
primary palate, are common malformations in humans and are often
attributed to deficiency or agenesis in midface development caused by
RA signalling disruption [56].
The eye malformations we observed in X. laevis larvae seem as well
to correlate to situations of hypovitaminosis A. In particular, the his-
tological analysis revealed that both the crystalline lens (in the most
severe situations) and the retina were affected. These malformations
were also visible in X. laevis larvae in which RA production or the
binding with RAR was inhibited [55] or in RARα-γmutant mice [57]. In
fact, RA is an important morphogen also for the correct formation of the
eye: the signal from RA would lead to the differentiation and correct
growth of portions of the eye originating from different embryonic cell
populations [58]. The presence of alternate areas of synthesis and de-
gradation of RA between the retina and the optical calyx, allows RA to
coordinate the eye formation by regulating biological activities of a
family of non-steroid hormone receptors, RARα/β/γ, and RXRα/β/γ.
Alterations in this RA distribution, by excess or deficiency of RA, result
in specific developmental abnormalities [59]. In addition to what is
stated in Goldberg [48], from recent studies it seems that β-carotene
could be involved in RA metabolism by close competing at nanomolar
level for the binding sites of nuclear receptors RARs, with consequent
alteration of RA signal [60,61].
It was reported that three apocarotenes produced by eccentric
cleavage of β carotene (β-14′-carotenal, β-14′-carotenoic acid and β-
apo-13-carotenone) act as antagonists for the three isoforms of RAR, α,
β, and γ. The binding affinity of these substances for the receptors is
within a nanomolar range and therefore they are close competitors of
RA itself. Although they can directly interact with the retinoid receptor
binding site, none of these apocarotenes is revealed able to significantly
activate the signal after binding with RARs receptors [61]. This aspect
could result in an anti-vitamin action of β-carotene, aggravated by
nano-encapsulation. It has been proposed, in fact, that the larger sur-
face area of the small lipid-based nano-capsule, could facilitate the
crossing of biological barriers, allowing the encapsulated lipophilic
substances to quickly and efficiently reach the biological targets and, by
consequence, enhance their bioavailability [62,63]. In addition, our
results obtained on neural crest cell migration (CRABPI im-
munostaining) support the hypothesis that the observed alterations
could be likely related to a disruption of the endogenous RA levels. In
fact, neural crest cell specification and migration from hindbrain to the
Fig. 7. X. laevis embryos at NF stage 26 immunostained with antibody anti-CRABP (C-D'). Magnification: 25X, 40× .
A, A’: X. laevis control embryo. Note the immunostained areas at the level of the oral cavity (o), of the frontal region (§), of the otic vesicle (>), of the optic vesicle
(*), and at the level of the branchial arches with separate neural crest migratory flows (> >).
B, B': X. laevis embryos exposed to NANO-β carotene 30 ng/mL. Note the altered migration of the neural crest cells: the migration streams appear fused forming a
ventrally indistinct immunostained mass with fusion regions (< <).
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branchial apparatus is driven by RA and RA deficiency could induce
similar migration defects in X. laevis models [64].
5. Conclusions
In this study, nano-encapsulated β-carotene was active in inducing
specific different malformation patterns, contrary to the bulk form that
was only active in inducing developmental delays. The results showed
that nano-encapsulation could change the toxicological profile of β-
carotene, suggesting that the encapsulation could increase the pro-vi-
tamin bioavailability at target structure or the bioavailability of β-
carotene-derived molecules able to inhibit retinoids signal. It can also
be supposed that nano-encapsulation could promote the formations of
these molecules and further evaluation are needed.
Although supplements during pregnancy with β-carotene are sug-
gested, results from this work prompt the necessity to evaluate the use
of nano-encapsulated β-carotene as it can cause teratogenic effects even
at low doses, which are considered safe for the bulk form, due to its
increased bioavailability.
Finally, due to its external development and accessibility
throughout all development and to its easily manipulating embryo, the
alternative animal models Frog Embryo Teratogenesis Assay: Xenopus-
FETAX resulted a rapid screening test applicable to study, and even-
tually to reconsider, micronutrient hazard evaluation after nano-en-
capsulation.
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